hiPSCs for predictive modelling of neurodegenerative diseases: dreaming the possible
Rivetti di Val Cervo P, Besusso D, Conforti P & Cattaneo E.
Nature Reviews Neurology. 2021 Mar 3:1–12. doi: 10.1038/s41582-021-00465-0. Epub ahead of print. PMID: 33658662; PMCID: PMC7928200.

Modeling autism-associated SHANK3 deficiency using human cortico-striatal organoids generated from single neural rosettes
Wang Y, Chiola S, Yang G, Russell C, Armstrong C J, Wu Y, Spampanato J, Tarboton P, Chang A N, Harmin D A, Vezzoli E, Besusso D, Cui J, Cattaneo E, Kubanek J, Shcheglovitov A.
bioRxiv preprint, version posted January 25, 2021, doi:https://doi.org/ 10.1101/2021.01.25.428022

Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington’s disease
Birolini G, Valenza M, Ottonelli I, Passoni A, Favagrossa M, Duskey JT, Bombaci M, Vandelli MA, Colombo L, Bagnati R, Caccia C, Leoni V, Taroni F, Forni F, Ruozi B, Salmona M, Tosi G, Cattaneo E.
J Control Release. 2021 Jan 5;330:587-598